Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
letter
. 1986 Jun;78(6):519–527.

Update in Cancer Chemotherapy: Gastrointestinal Cancer, Cancer of the Pancreas

Jane C Wright
PMCID: PMC2571298  PMID: 3525851

Abstract

An update of the state of the art of cancer chemotherapeutic treatment of gastrointestinal tract cancer is described in this multiple-part series. A review of cancers of the colon, rectum, and anus was published in the April and May issues of the Journal. In this section, cancer of the pancreas and its treatment with surgery, radiation therapy, chemotherapy, and adjuvant chemotherapy are discussed.

Full text

PDF
522

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bitran J. D., Desser R. K., Kozloff M. F., Billings A. A., Shapiro C. M. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM). Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2049–2051. [PubMed] [Google Scholar]
  2. Broder L. E., Carter S. K. Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients. Ann Intern Med. 1973 Jul;79(1):108–118. doi: 10.7326/0003-4819-79-1-108. [DOI] [PubMed] [Google Scholar]
  3. Bukowski R. M., Balcerzak S. P., O'Bryan R. M., Bonnet J. D., Chen T. T. Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest Oncology Group study. Cancer. 1983 Nov 1;52(9):1577–1582. doi: 10.1002/1097-0142(19831101)52:9<1577::aid-cncr2820520906>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  4. Bukowski R. M., Schacter L. P., Groppe C. W., Hewlett J. S., Weick J. K., Livingston R. B. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma. Cancer. 1982 Jul 15;50(2):197–200. doi: 10.1002/1097-0142(19820715)50:2<197::aid-cncr2820500204>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  5. Buroker T., Kim P. N., Groppe C., McCracken J., O'Bryan R., Panettiere F., Costanzi J., Bottomley R., King G. W., Bonnet J. 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study. Cancer. 1979 Oct;44(4):1215–1221. doi: 10.1002/1097-0142(197910)44:4<1215::aid-cncr2820440408>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  6. Carter S. K., Comis R. L. The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma. Cancer Treat Rev. 1975 Sep;2(3):193–214. doi: 10.1016/s0305-7372(75)80003-x. [DOI] [PubMed] [Google Scholar]
  7. Coutsoftides T., Macdonald J., Shibata H. R. Carcinoma of the pancreas and periampullary region: a 41 year experience. Ann Surg. 1977 Dec;186(6):730–733. doi: 10.1097/00000658-197712000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crile G., Jr The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet. 1970 Jun;130(6):1049–1053. [PubMed] [Google Scholar]
  9. Cullinan S. A., Moertel C. G., Fleming T. R., Rubin J. R., Krook J. E., Everson L. K., Windschitl H. E., Twito D. I., Marschke R. F., Foley J. F. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. JAMA. 1985 Apr 12;253(14):2061–2067. [PubMed] [Google Scholar]
  10. Dobelbower R. R., Jr The radiotherapy of pancreatic cancer. Semin Oncol. 1979 Sep;6(3):378–389. [PubMed] [Google Scholar]
  11. Haslam J. B., Cavanaugh P. J., Stroup S. L. Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreas. Cancer. 1973 Dec;32(6):1341–1345. doi: 10.1002/1097-0142(197312)32:6<1341::aid-cncr2820320609>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  12. Horton J., Gelber R. D., Engstrom P., Falkson G., Moertel C., Brodovsky H., Douglass H. Trials of single-agent and combination chemotherapy for advanced cancer of the pancreas. Cancer Treat Rep. 1981 Jan-Feb;65(1-2):65–68. [PubMed] [Google Scholar]
  13. Ihse I., Lilja P., Arnesjö B., Bengmark S. Total pancreatectomy for cancer. An appraisal of 65 cases. Ann Surg. 1977 Dec;186(6):675–680. doi: 10.1097/00000658-197712000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kovach J. S., Moertel C. G., Schutt A. J., Hahn R. G., Reitemeier R. J. Proceedings: A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer. Cancer. 1974 Feb;33(2):563–567. doi: 10.1002/1097-0142(197402)33:2<563::aid-cncr2820330235>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  15. Lokich J. J., Skarin A. T. Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma. Cancer Chemother Rep. 1972 Oct;56(5):653–657. [PubMed] [Google Scholar]
  16. MacMahon B. Risk factors for cancer of the pancreas. Cancer. 1982 Dec 1;50(11 Suppl):2676–2680. [PubMed] [Google Scholar]
  17. Mallinson C. N., Rake M. O., Cocking J. B., Fox C. A., Cwynarski M. T., Diffey B. L., Jackson G. A., Hanley J., Wass V. J. Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial. Br Med J. 1980 Dec 13;281(6255):1589–1591. doi: 10.1136/bmj.281.6255.1589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Moertel C. G. Chemotherapy of gastrointestinal cancer. Clin Gastroenterol. 1976 Sep;5(3):777–793. [PubMed] [Google Scholar]
  19. Moertel C. G., Childs D. S., Jr, Reitemeier R. J., Colby M. Y., Jr, Holbrook M. A. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet. 1969 Oct 25;2(7626):865–867. doi: 10.1016/s0140-6736(69)92326-5. [DOI] [PubMed] [Google Scholar]
  20. Moertel C. G., Douglas H. O., Jr, Hanley J., Carbone P. P. Treatment of advanced adenocarcinoma of the pancreas with combinations of streptozotocin plus 5-fluorouracil and streptozotocin plus cyclophosphamide. Cancer. 1977 Aug;40(2):605–608. doi: 10.1002/1097-0142(197708)40:2<605::aid-cncr2820400202>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  21. Moertel C. G., Douglass H. O., Hanley J., Carbone P. P. Phase II study of methyl-CCNU in the treatment of advanced pancreatic carcinoma. Cancer Treat Rep. 1976 Nov;60(11):1659–1661. [PubMed] [Google Scholar]
  22. Moertel C. G., Engstrom P., Lavin P. T., Gelber R. D., Carbone P. P. Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones". Surgery. 1979 May;85(5):509–513. [PubMed] [Google Scholar]
  23. O'Connell M. J. Current status of chemotherapy for advanced pancreatic and gastric cancer. J Clin Oncol. 1985 Jul;3(7):1032–1039. doi: 10.1200/JCO.1985.3.7.1032. [DOI] [PubMed] [Google Scholar]
  24. Sato T., Saitoh Y., Noto N., Matsuno S. Follow-up studies of radical resection for pancreaticoduodenal cancer. Ann Surg. 1977 Nov;186(5):581–588. doi: 10.1097/00000658-197711000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Schein P. S., Lavin P. T., Moertel C. G., Frytak S., Hahn R. G., O'Connell M. J., Reitemeier R. J., Rubin J., Schutt A. J., Weiland L. H. Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group Report. Cancer. 1978 Jul;42(1):19–22. doi: 10.1002/1097-0142(197807)42:1<19::aid-cncr2820420103>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  26. Smith F. P., Hoth D. F., Levin B., Karlin D. A., MacDonald J. S., Woolley P. V., 3rd, Schein P. S. 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas. Cancer. 1980 Nov 1;46(9):2014–2018. doi: 10.1002/1097-0142(19801101)46:9<2014::aid-cncr2820460920>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  27. Stephens R. L., Hoogstraten B., Haas C., Clark G. Pancreatic cancer treated with carmustine, fluorouracil, and spironolactone: a randomized study. Arch Intern Med. 1978 Jan;138(1):115–117. [PubMed] [Google Scholar]
  28. Tepper J., Nardi G., Sutt H. Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy. Cancer. 1976 Mar;37(3):1519–1524. doi: 10.1002/1097-0142(197603)37:3<1519::aid-cncr2820370340>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  29. Waddell W. R. Chemotherapy for carcinoma of the pancreas. Surgery. 1973 Sep;74(3):420–429. [PubMed] [Google Scholar]
  30. Wiggans R. G., Woolley P. V., Macdonald J. S., Smythe T., Ueno W., Schein P. S. Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer. Cancer. 1978 Feb;41(2):387–391. doi: 10.1002/1097-0142(197802)41:2<387::aid-cncr2820410201>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES